Trust Your Gut: Improving the Physician Assistant's Acumen in Identifying and Managing Irritable Bowel Syndrome and Chronic Idiopathic Constipation

 

Release Date: October 15, 2015

Last Reviewed: October 3, 2015

Expiration Date: October 15, 2016

*This activity expired for credit on October 15, 2016 and is no longer available for credit
 

Physician Assistant

Chapel Hill Primary Care

Drossman Gastroenterology

Chapel Hill, NC

 

Professor of Medicine

Division of Gastroenterology

University of South Alabama

Mobile, AL

 

Associate Professor of Medicine

Division of Gastroenterology and Hepatology

Mayo College of Medicine

Scottsdale, AZ

 

Burlington, NC

 

Atlanta, GA

This activity is provided by Paradigm Medical Communications, LLC.  

 

This activity has been designed to address the educational needs of physician assistants (PAs) with an interest in the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC). This activity will also benefit other healthcare providers (HCPs) interested in the diagnosis and management of IBS and CIC.

 

Upon proper completion of this activity, participants should be better able to:

 

 

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program has been reviewed and is approved for a maximum of 1.00 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date of 10/15/2015 . Participants may submit the post-test at any time during that period.

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

This activity is supported by educational grants from Allergan, Inc, and Prometheus Laboratories, Inc.

 

To receive a CME certificate of participation, you should:

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

Successful completion of the post-test is required to earn Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

 

There is no fee required for participation in this activity.

For Desktops (Windows/Mac)

Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

 

For Tablets (iPad/Android/Surface)

iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

 

In accordance with ACCME and AAPA requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

 

 

Speakers Bureau: QOL Medical, LLC, Synergy Pharmaceuticals Inc, Ironwood Pharmaceuticals, Inc

 

 

 

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

 

Independent peer reviewers have no financial relationships to disclose.

 

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the AAPA and ACCME’s Standards for Commercial Support of Continuing Medical Education.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

 

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

 

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

 

Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

 

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.

 

©2015 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.